SEC Form 4 · accession 0001209191-15-086851
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn A. Tetrault
Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2015 | P | 9,500 | $8.21 | A | 14,560 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $6.66 | holding | — | — | — | Jul 15, 2016 | Jul 15, 2020 | Common Stock | 0 | 10,000 | D |
Explanation of responses
- F1On July 15, 2015, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.